In this enlightening discussion, aging experts Steven Austad, Richard Miller, and Matt Kaeberlein delve into the science of aging. They explore the connection between healthspan and lifespan, emphasizing effective interventions like rapamycin and senolytics. The panel critiques the funding challenges in aging research and advocates for more focus on geroscience. Additionally, they examine the complexities of biological age measurements and the potential of GLP-1 receptor agonists in promoting longevity. Packed with humor, insights, and scientific rigor, this conversation is a must-listen!

Richard Miller, a pathology professor at the University of Michigan and architect of the Interventions Testing Program, dives into the intriguing world of longevity research. He discusses groundbreaking findings on drugs like rapamycin and metformin, shedding light on their effects on lifespan in mice. Miller also explores the myths surrounding aging, the value of negative results from studies, and the nuances of using compounds like acarbose and nicotinamide riboside. His insights challenge conventional views and highlight the complexities of drug testing in the quest for a longer life.